Zhang Z, Chen C, Liu C, Sun P, Liu P, Fang S
Sci Adv. 2025; 11(10):eadq4266.
PMID: 40053593
PMC: 11887815.
DOI: 10.1126/sciadv.adq4266.
Fischer F, Demarco B, Min F, Yeap H, De Nardo D, Chen K
Sci Adv. 2025; 11(10):eadq1047.
PMID: 40053580
PMC: 11887814.
DOI: 10.1126/sciadv.adq1047.
Zhang L, Gao Y, Zhou H, Liang X, Jiang X, Gong W
PLoS Pathog. 2025; 21(1):e1012915.
PMID: 39869629
PMC: 11801707.
DOI: 10.1371/journal.ppat.1012915.
Fandrey C, Jentzsch M, Konopka P, Hoch A, Blumenstock K, Zackria A
Nat Biotechnol. 2024; .
PMID: 39702735
DOI: 10.1038/s41587-024-02516-5.
Wang T, Sun G, Tao B
Front Aging Neurosci. 2024; 16:1480502.
PMID: 39411285
PMC: 11474915.
DOI: 10.3389/fnagi.2024.1480502.
Aggravating mechanisms from COVID-19.
Lee J, Sergi C, Kast R, Kanwar B, Bourbeau J, Oh S
Virol J. 2024; 21(1):228.
PMID: 39334442
PMC: 11430051.
DOI: 10.1186/s12985-024-02506-8.
The human disease-associated gene ZNFX1 controls inflammation through inhibition of the NLRP3 inflammasome.
Huang J, Wang Y, Jia X, Zhao C, Zhang M, Bao M
EMBO J. 2024; 43(22):5469-5493.
PMID: 39333773
PMC: 11574294.
DOI: 10.1038/s44318-024-00236-9.
From fat to fire: The lipid-inflammasome connection.
Anand P
Immunol Rev. 2024; 329(1):e13403.
PMID: 39327931
PMC: 11744241.
DOI: 10.1111/imr.13403.
Human NLRP3 inflammasome activation leads to formation of condensate at the microtubule organizing center.
Wang J, Wu M, Magupalli V, Dahlberg P, Wu H, Jensen G
bioRxiv. 2024; .
PMID: 39314395
PMC: 11419111.
DOI: 10.1101/2024.09.12.612739.
S-acylation of NLRP3 provides a nigericin sensitive gating mechanism that controls access to the Golgi.
Williams D, Peden A
Elife. 2024; 13.
PMID: 39263961
PMC: 11392533.
DOI: 10.7554/eLife.94302.
Inflammasome components as new therapeutic targets in inflammatory disease.
Coll R, Schroder K
Nat Rev Immunol. 2024; 25(1):22-41.
PMID: 39251813
DOI: 10.1038/s41577-024-01075-9.
Implication of the LRR Domain in the Regulation and Activation of the NLRP3 Inflammasome.
Cescato M, Zhu Y, Le Corre L, Py B, Georgin-Lavialle S, Rodero M
Cells. 2024; 13(16).
PMID: 39195255
PMC: 11352923.
DOI: 10.3390/cells13161365.
Genetic and epigenetic regulation of inflammasomes: Role in atherosclerosis.
Yalcinkaya M, Tall A
Atherosclerosis. 2024; 396:118541.
PMID: 39111028
PMC: 11374466.
DOI: 10.1016/j.atherosclerosis.2024.118541.
Kaempferol Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis (NASH) by Suppressing Neutrophil-Mediated NLRP3-ASC/TMS1-Caspase 3 Signaling.
Yang H, Li D, Gao G
Molecules. 2024; 29(11).
PMID: 38893506
PMC: 11173805.
DOI: 10.3390/molecules29112630.
Type 1 diabetes impairs the activity of rat testicular somatic and germ cells through NRF2/NLRP3 pathway-mediated oxidative stress.
Venditti M, Romano M, Boccella S, Haddadi A, Biasi A, Maione S
Front Endocrinol (Lausanne). 2024; 15:1399256.
PMID: 38818504
PMC: 11137174.
DOI: 10.3389/fendo.2024.1399256.
Post-translational control of NLRP3 inflammasome signaling.
OKeefe M, Dubyak G, Abbott D
J Biol Chem. 2024; 300(6):107386.
PMID: 38763335
PMC: 11245928.
DOI: 10.1016/j.jbc.2024.107386.
Pattern-Recognition Receptors and Immunometabolic Reprogramming: What We Know and What to Explore.
Kumar V, Stewart Iv J
J Innate Immun. 2024; 16(1):295-323.
PMID: 38740018
PMC: 11250681.
DOI: 10.1159/000539278.
Spatiotemporal proteomic profiling of cellular responses to NLRP3 agonists.
Hollingsworth L, Veeraraghavan P, Paulo J, Harper J
bioRxiv. 2024; .
PMID: 38659763
PMC: 11042255.
DOI: 10.1101/2024.04.19.590338.
The NLR family of innate immune and cell death sensors.
Sundaram B, Tweedell R, Kumar S, Kanneganti T
Immunity. 2024; 57(4):674-699.
PMID: 38599165
PMC: 11112261.
DOI: 10.1016/j.immuni.2024.03.012.
Dimethyl fumarate covalently modifies Cys673 of NLRP3 to exert anti-inflammatory effects.
Hu H, Cai Y, Shi Y, Zhang S, Yu X, Ma T
iScience. 2024; 27(4):109544.
PMID: 38585664
PMC: 10995871.
DOI: 10.1016/j.isci.2024.109544.